

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.10666242 |
| 2 | deoxyribonucleotide catabolic process (GO:0009264) | 4.60004593 |
| 3 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.56291708 |
| 4 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.46723614 |
| 5 | base-excision repair, AP site formation (GO:0006285) | 4.44469996 |
| 6 | response to pheromone (GO:0019236) | 4.27885996 |
| 7 | deoxyribose phosphate catabolic process (GO:0046386) | 4.26909141 |
| 8 | anterograde synaptic vesicle transport (GO:0048490) | 4.21647536 |
| 9 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.16790707 |
| 10 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.16790707 |
| 11 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.00381876 |
| 12 | negative regulation of B cell apoptotic process (GO:0002903) | 3.99106324 |
| 13 | neuromuscular process controlling posture (GO:0050884) | 3.69982709 |
| 14 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.67663336 |
| 15 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.61496029 |
| 16 | positive regulation of prostaglandin secretion (GO:0032308) | 3.56049190 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 3.55021979 |
| 18 | mature B cell differentiation involved in immune response (GO:0002313) | 3.51401857 |
| 19 | protein insertion into membrane (GO:0051205) | 3.45988946 |
| 20 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.45862603 |
| 21 | activation of MAPKKK activity (GO:0000185) | 3.45164249 |
| 22 | nucleotide salvage (GO:0043173) | 3.44623295 |
| 23 | negative regulation of microtubule polymerization (GO:0031115) | 3.42734924 |
| 24 | anterograde axon cargo transport (GO:0008089) | 3.42087947 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.40060707 |
| 26 | sequestering of actin monomers (GO:0042989) | 3.33277300 |
| 27 | deoxyribose phosphate metabolic process (GO:0019692) | 3.32343027 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31923213 |
| 29 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.31415867 |
| 30 | protein targeting to mitochondrion (GO:0006626) | 3.29704504 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.27050275 |
| 32 | establishment of protein localization to mitochondrion (GO:0072655) | 3.25899649 |
| 33 | synaptic vesicle exocytosis (GO:0016079) | 3.25746425 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.22397573 |
| 35 | GDP-mannose metabolic process (GO:0019673) | 3.22001045 |
| 36 | neurofilament cytoskeleton organization (GO:0060052) | 3.20453641 |
| 37 | iron-sulfur cluster assembly (GO:0016226) | 3.18646409 |
| 38 | metallo-sulfur cluster assembly (GO:0031163) | 3.18646409 |
| 39 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.13854913 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13433030 |
| 41 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.03366022 |
| 42 | purine-containing compound salvage (GO:0043101) | 3.02661971 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 3.01995789 |
| 44 | chaperone-mediated protein transport (GO:0072321) | 2.99527688 |
| 45 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.98269314 |
| 46 | heme biosynthetic process (GO:0006783) | 2.97083368 |
| 47 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.96787508 |
| 48 | regulation of B cell apoptotic process (GO:0002902) | 2.93284876 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90265959 |
| 50 | endosome to pigment granule transport (GO:0043485) | 2.89134718 |
| 51 | endosome to melanosome transport (GO:0035646) | 2.89134718 |
| 52 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.87430424 |
| 53 | protein complex biogenesis (GO:0070271) | 2.87085932 |
| 54 | protein localization to mitochondrion (GO:0070585) | 2.84187246 |
| 55 | regulation of mitochondrial translation (GO:0070129) | 2.82599050 |
| 56 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.82505995 |
| 57 | neuronal action potential propagation (GO:0019227) | 2.81391001 |
| 58 | NADH metabolic process (GO:0006734) | 2.80327312 |
| 59 | glutathione biosynthetic process (GO:0006750) | 2.80077243 |
| 60 | axon cargo transport (GO:0008088) | 2.79879871 |
| 61 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.78960946 |
| 62 | NADH dehydrogenase complex assembly (GO:0010257) | 2.78960946 |
| 63 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.78960946 |
| 64 | melanosome transport (GO:0032402) | 2.78218515 |
| 65 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.76673540 |
| 66 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.75340206 |
| 67 | respiratory system process (GO:0003016) | 2.75314200 |
| 68 | autophagic vacuole fusion (GO:0000046) | 2.74502094 |
| 69 | deoxyribonucleotide metabolic process (GO:0009262) | 2.74441858 |
| 70 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.74042359 |
| 71 | mitochondrial calcium ion transport (GO:0006851) | 2.73325994 |
| 72 | proteasome assembly (GO:0043248) | 2.72615511 |
| 73 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71806425 |
| 74 | viral transcription (GO:0019083) | 2.71643722 |
| 75 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71281057 |
| 76 | negative regulation of ligase activity (GO:0051352) | 2.71281057 |
| 77 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.70786752 |
| 78 | GMP metabolic process (GO:0046037) | 2.69928523 |
| 79 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69575007 |
| 80 | peptidyl-histidine modification (GO:0018202) | 2.68998684 |
| 81 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.68829887 |
| 82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.68463956 |
| 83 | ribonucleoprotein complex disassembly (GO:0032988) | 2.68242876 |
| 84 | translational elongation (GO:0006414) | 2.68051516 |
| 85 | regulation of prostaglandin secretion (GO:0032306) | 2.67620014 |
| 86 | glutamate secretion (GO:0014047) | 2.67420256 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67081055 |
| 88 | response to peptidoglycan (GO:0032494) | 2.66503667 |
| 89 | dopamine receptor signaling pathway (GO:0007212) | 2.65613065 |
| 90 | respiratory chain complex IV assembly (GO:0008535) | 2.65504270 |
| 91 | ATP synthesis coupled proton transport (GO:0015986) | 2.65398615 |
| 92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.65398615 |
| 93 | GPI anchor biosynthetic process (GO:0006506) | 2.65109831 |
| 94 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.64388605 |
| 95 | pyrimidine-containing compound salvage (GO:0008655) | 2.61747189 |
| 96 | pyrimidine nucleoside salvage (GO:0043097) | 2.61747189 |
| 97 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.61423288 |
| 98 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.61408182 |
| 99 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.60052223 |
| 100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.59373707 |
| 101 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.59215817 |
| 102 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.59208973 |
| 103 | pigment granule transport (GO:0051904) | 2.58673692 |
| 104 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.58339329 |
| 105 | * SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 2.58258459 |
| 106 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.57618761 |
| 107 | prostaglandin biosynthetic process (GO:0001516) | 2.57511268 |
| 108 | prostanoid biosynthetic process (GO:0046457) | 2.57511268 |
| 109 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.56307690 |
| 110 | translational termination (GO:0006415) | 2.55968836 |
| 111 | heme metabolic process (GO:0042168) | 2.55772941 |
| 112 | UV protection (GO:0009650) | 2.55304889 |
| 113 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.54640287 |
| 114 | ncRNA 3-end processing (GO:0043628) | 2.53988312 |
| 115 | cotranslational protein targeting to membrane (GO:0006613) | 2.53909998 |
| 116 | establishment of melanosome localization (GO:0032401) | 2.53168181 |
| 117 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.52964468 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 2.51927605 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.51784812 |
| 120 | protein targeting to ER (GO:0045047) | 2.51148059 |
| 121 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.50237000 |
| 122 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.49806527 |
| 123 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.49680529 |
| 124 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.49649031 |
| 125 | melanosome localization (GO:0032400) | 2.49563820 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48921066 |
| 127 | protein localization to endoplasmic reticulum (GO:0070972) | 2.47603972 |
| 128 | cellular metabolic compound salvage (GO:0043094) | 2.47159808 |
| 129 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.47151044 |
| 130 | Peyers patch development (GO:0048541) | 2.47151044 |
| 131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46870739 |
| 132 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.46773636 |
| 133 | ribosomal small subunit assembly (GO:0000028) | 2.46671682 |
| 134 | synaptic vesicle transport (GO:0048489) | 2.46567954 |
| 135 | establishment of synaptic vesicle localization (GO:0097480) | 2.46567954 |
| 136 | mature B cell differentiation (GO:0002335) | 2.46335535 |
| 137 | regulation of synapse structural plasticity (GO:0051823) | 2.46052079 |
| 138 | nucleobase catabolic process (GO:0046113) | 2.45791269 |
| 139 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.44473656 |
| 140 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.44473656 |
| 141 | negative regulation of interleukin-12 production (GO:0032695) | 2.43213265 |
| 142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.43145647 |
| 143 | regulation of neuron projection regeneration (GO:0070570) | 2.42921238 |
| 144 | regulation of axon regeneration (GO:0048679) | 2.42921238 |
| 145 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.42107688 |
| 146 | protein localization to synapse (GO:0035418) | 2.41749093 |
| 147 | cytochrome complex assembly (GO:0017004) | 2.40215073 |
| 148 | reactive oxygen species biosynthetic process (GO:1903409) | 2.40096746 |
| 149 | purine nucleotide salvage (GO:0032261) | 2.39885803 |
| 150 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39410636 |
| 151 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.38784393 |
| 152 | mitochondrial RNA metabolic process (GO:0000959) | 2.38574824 |
| 153 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.37726186 |
| 154 | regulation of defense response to virus by virus (GO:0050690) | 2.36738094 |
| 155 | establishment of pigment granule localization (GO:0051905) | 2.35650410 |
| 156 | GTP biosynthetic process (GO:0006183) | 2.33874193 |
| 157 | estrogen biosynthetic process (GO:0006703) | 2.30491347 |
| 158 | lipoxygenase pathway (GO:0019372) | 2.29760504 |
| 159 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.29684836 |
| 160 | regulation of chemokine biosynthetic process (GO:0045073) | 2.29286377 |
| 161 | regulation of mast cell degranulation (GO:0043304) | 2.28606541 |
| 162 | negative regulation of amino acid transport (GO:0051956) | 2.28557772 |
| 163 | respiratory electron transport chain (GO:0022904) | 2.28467893 |
| 164 | response to protozoan (GO:0001562) | 2.27766070 |
| 165 | establishment of mitochondrion localization (GO:0051654) | 2.27569293 |
| 166 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.27378597 |
| 167 | phagosome maturation (GO:0090382) | 2.27246439 |
| 168 | positive regulation of icosanoid secretion (GO:0032305) | 2.26952046 |
| 169 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.26637354 |
| 170 | electron transport chain (GO:0022900) | 2.25798728 |
| 171 | mannosylation (GO:0097502) | 2.23482704 |
| 172 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.23416519 |
| 173 | regulation of protein kinase A signaling (GO:0010738) | 2.22330364 |
| 174 | positive regulation of B cell differentiation (GO:0045579) | 2.22299744 |
| 175 | GPI anchor metabolic process (GO:0006505) | 2.19691191 |
| 176 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.19508006 |
| 177 | B cell mediated immunity (GO:0019724) | 2.18793052 |
| 178 | positive regulation of TOR signaling (GO:0032008) | 2.18786365 |
| 179 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.17072497 |
| 180 | pentose metabolic process (GO:0019321) | 2.16896701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92274009 |
| 2 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24480701 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.00461719 |
| 4 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.83236187 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68313889 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.60930294 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53457245 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48665477 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33114279 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.29831810 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.27085475 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.24205775 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22720225 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21798403 |
| 15 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 2.11089649 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.08704138 |
| 17 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.05576454 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04806226 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.04535083 |
| 20 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.03634208 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02856232 |
| 22 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01643487 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99670529 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97722057 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96864349 |
| 26 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.93350287 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91961443 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88518588 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86815587 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.84895757 |
| 31 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.83937093 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83267043 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81422215 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79166844 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77901276 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77365152 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76819129 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71621864 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.66407705 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66376081 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65680499 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65385792 |
| 43 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.62046537 |
| 44 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61634433 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61481462 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61122805 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.57604725 |
| 48 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.57295632 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56078486 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54911119 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52440678 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52058314 |
| 53 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50289646 |
| 54 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.46346950 |
| 55 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.45360624 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45194691 |
| 57 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.44155028 |
| 58 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.44003644 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43713301 |
| 60 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42823269 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41969629 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40749361 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38073772 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.37876418 |
| 65 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36764211 |
| 66 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34547087 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33948063 |
| 68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32629819 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32100904 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31766277 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.31716185 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30307785 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29884505 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29805588 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29456350 |
| 76 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29017874 |
| 77 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28756307 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28032570 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27974707 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27712073 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.27679004 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26904444 |
| 83 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.26780573 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26274113 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25992498 |
| 86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25906113 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.25868415 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25151957 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24941885 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24533349 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23650869 |
| 92 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.22948105 |
| 93 | * P300_27268052_Chip-Seq_Bcells_Human | 1.22906117 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22310394 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21702043 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21617861 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 1.21202809 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20393970 |
| 99 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18769981 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18551964 |
| 101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.18387617 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18251684 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17581018 |
| 104 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17086033 |
| 105 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17066392 |
| 106 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16327176 |
| 107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16030624 |
| 108 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.14715716 |
| 109 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13672429 |
| 110 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13502402 |
| 111 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13329854 |
| 112 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12909106 |
| 113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12478706 |
| 114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.12307687 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12235036 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12003196 |
| 117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12002942 |
| 118 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.11675632 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11557508 |
| 120 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10445489 |
| 121 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09979095 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09024970 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08952092 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07629903 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06708016 |
| 126 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.06489882 |
| 127 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.06411593 |
| 128 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05674568 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05279330 |
| 130 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05186340 |
| 131 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04904955 |
| 132 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03809291 |
| 133 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03164140 |
| 134 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02438971 |
| 135 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01956840 |
| 136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01732512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.58145292 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.31684272 |
| 3 | MP0001968_abnormal_touch/_nociception | 3.31515170 |
| 4 | MP0001986_abnormal_taste_sensitivity | 3.03142798 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.86397577 |
| 6 | MP0002736_abnormal_nociception_after | 2.72249466 |
| 7 | MP0003303_peritoneal_inflammation | 2.62933393 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.55693124 |
| 9 | MP0009278_abnormal_bone_marrow | 2.51378460 |
| 10 | MP0008260_abnormal_autophagy | 2.41892685 |
| 11 | MP0006276_abnormal_autonomic_nervous | 2.37751146 |
| 12 | MP0005083_abnormal_biliary_tract | 2.22926917 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.17515735 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.17515735 |
| 15 | MP0005451_abnormal_body_composition | 2.16612161 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.15095583 |
| 17 | MP0004510_myositis | 2.14629869 |
| 18 | MP0009840_abnormal_foam_cell | 2.12284566 |
| 19 | MP0004858_abnormal_nervous_system | 2.10997445 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.10393658 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 2.05890019 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.03206302 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 2.01366558 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.88577973 |
| 25 | MP0003879_abnormal_hair_cell | 1.86972681 |
| 26 | MP0010386_abnormal_urinary_bladder | 1.84038863 |
| 27 | MP0004142_abnormal_muscle_tone | 1.82349204 |
| 28 | MP0002063_abnormal_learning/memory/cond | 1.82084919 |
| 29 | MP0002419_abnormal_innate_immunity | 1.76016385 |
| 30 | MP0003075_altered_response_to | 1.74949366 |
| 31 | MP0003724_increased_susceptibility_to | 1.70461220 |
| 32 | MP0003880_abnormal_central_pattern | 1.67932905 |
| 33 | MP0001970_abnormal_pain_threshold | 1.67854976 |
| 34 | MP0003329_amyloid_beta_deposits | 1.67498582 |
| 35 | MP0004270_analgesia | 1.64442291 |
| 36 | MP0003122_maternal_imprinting | 1.63871469 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.63755504 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.61868463 |
| 39 | MP0002272_abnormal_nervous_system | 1.61032109 |
| 40 | MP0001800_abnormal_humoral_immune | 1.59821779 |
| 41 | MP0002064_seizures | 1.59460777 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.56250151 |
| 43 | MP0005387_immune_system_phenotype | 1.55852730 |
| 44 | MP0001790_abnormal_immune_system | 1.55852730 |
| 45 | MP0009764_decreased_sensitivity_to | 1.55030422 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.54575240 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.53457407 |
| 48 | MP0003436_decreased_susceptibility_to | 1.53193599 |
| 49 | MP0001819_abnormal_immune_cell | 1.52697716 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.51262425 |
| 51 | MP0002184_abnormal_innervation | 1.50412757 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.50240082 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.49716240 |
| 54 | MP0003787_abnormal_imprinting | 1.46207670 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.44286031 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.42699361 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.41054753 |
| 58 | MP0002751_abnormal_autonomic_nervous | 1.39951866 |
| 59 | MP0004043_abnormal_pH_regulation | 1.38874484 |
| 60 | MP0009745_abnormal_behavioral_response | 1.35905775 |
| 61 | MP0001905_abnormal_dopamine_level | 1.33026370 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.31668680 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.31282395 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.30831337 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 1.30329546 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.28564343 |
| 67 | MP0001873_stomach_inflammation | 1.28231482 |
| 68 | MP0001984_abnormal_olfaction | 1.26462088 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.24313325 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.23288329 |
| 71 | MP0005166_decreased_susceptibility_to | 1.22940963 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.21629892 |
| 73 | MP0000716_abnormal_immune_system | 1.20321576 |
| 74 | MP0006292_abnormal_olfactory_placode | 1.19206444 |
| 75 | MP0003195_calcinosis | 1.18533251 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.17063688 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.16241037 |
| 78 | MP0002822_catalepsy | 1.14894288 |
| 79 | MP0001764_abnormal_homeostasis | 1.14285847 |
| 80 | MP0000343_altered_response_to | 1.14252444 |
| 81 | MP0000490_abnormal_crypts_of | 1.13258811 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.11659975 |
| 83 | MP0009046_muscle_twitch | 1.11183112 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 1.10989698 |
| 85 | MP0004147_increased_porphyrin_level | 1.08092294 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.07595051 |
| 87 | MP0000015_abnormal_ear_pigmentation | 1.06966553 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.06957604 |
| 89 | MP0003186_abnormal_redox_activity | 1.05532974 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 1.03516588 |
| 91 | MP0003866_abnormal_defecation | 1.03428614 |
| 92 | MP0000955_abnormal_spinal_cord | 1.02879286 |
| 93 | MP0002429_abnormal_blood_cell | 1.02232150 |
| 94 | MP0002653_abnormal_ependyma_morphology | 1.01145066 |
| 95 | MP0000358_abnormal_cell_content/ | 1.00824954 |
| 96 | MP0001663_abnormal_digestive_system | 0.99778978 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99769774 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99590771 |
| 99 | MP0002722_abnormal_immune_system | 0.96468322 |
| 100 | MP0002102_abnormal_ear_morphology | 0.95439727 |
| 101 | MP0005448_abnormal_energy_balance | 0.95115917 |
| 102 | MP0002132_abnormal_respiratory_system | 0.94661865 |
| 103 | MP0005000_abnormal_immune_tolerance | 0.94572446 |
| 104 | MP0005410_abnormal_fertilization | 0.92824413 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.92673538 |
| 106 | MP0001529_abnormal_vocalization | 0.91664400 |
| 107 | MP0009379_abnormal_foot_pigmentation | 0.91418532 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.90829387 |
| 109 | MP0009785_altered_susceptibility_to | 0.90608084 |
| 110 | MP0000685_abnormal_immune_system | 0.90167948 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.90023693 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.87535564 |
| 113 | MP0008874_decreased_physiological_sensi | 0.85456113 |
| 114 | MP0002882_abnormal_neuron_morphology | 0.85195535 |
| 115 | MP0005360_urolithiasis | 0.84490492 |
| 116 | MP0004924_abnormal_behavior | 0.84264304 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.84264304 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.82476501 |
| 119 | MP0000604_amyloidosis | 0.82009989 |
| 120 | MP0002398_abnormal_bone_marrow | 0.81662189 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.81478160 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.80727852 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.80516381 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.79824088 |
| 125 | MP0002723_abnormal_immune_serum | 0.78728742 |
| 126 | MP0003718_maternal_effect | 0.78207241 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.77023662 |
| 128 | MP0001853_heart_inflammation | 0.76830042 |
| 129 | MP0006082_CNS_inflammation | 0.76741200 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.76681493 |
| 131 | MP0005645_abnormal_hypothalamus_physiol | 0.75732116 |
| 132 | MP0003123_paternal_imprinting | 0.75609465 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.74990437 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.74593463 |
| 135 | MP0008469_abnormal_protein_level | 0.74257090 |
| 136 | MP0005075_abnormal_melanosome_morpholog | 0.74175183 |
| 137 | MP0005535_abnormal_body_temperature | 0.73934067 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.73413027 |
| 139 | MP0002078_abnormal_glucose_homeostasis | 0.72776910 |
| 140 | MP0005671_abnormal_response_to | 0.72600733 |
| 141 | MP0002405_respiratory_system_inflammati | 0.71335032 |
| 142 | MP0001845_abnormal_inflammatory_respons | 0.71277704 |
| 143 | MP0003763_abnormal_thymus_physiology | 0.71040098 |
| 144 | MP0005025_abnormal_response_to | 0.69552192 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69447724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.74944437 |
| 2 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.74944437 |
| 3 | Myokymia (HP:0002411) | 3.88770110 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.75516872 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.61809697 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.59712194 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.59712194 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.59712194 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.43757856 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.27196006 |
| 11 | Poor suck (HP:0002033) | 3.23098059 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.19902066 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18413595 |
| 14 | Obstructive lung disease (HP:0006536) | 3.18413595 |
| 15 | Abnormality of magnesium homeostasis (HP:0004921) | 3.12533656 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.11433700 |
| 17 | Visual hallucinations (HP:0002367) | 3.04699531 |
| 18 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.98694591 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97512244 |
| 20 | Gout (HP:0001997) | 2.93698761 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.91962782 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.91156208 |
| 23 | Hepatic necrosis (HP:0002605) | 2.90054711 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.88860787 |
| 25 | Dysostosis multiplex (HP:0000943) | 2.88491595 |
| 26 | Polyphagia (HP:0002591) | 2.82132948 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 2.80716060 |
| 28 | Emotional lability (HP:0000712) | 2.77930440 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77128867 |
| 30 | Delusions (HP:0000746) | 2.76961758 |
| 31 | Failure to thrive in infancy (HP:0001531) | 2.72529955 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.70749436 |
| 33 | Mesangial abnormality (HP:0001966) | 2.70306675 |
| 34 | Increased serum lactate (HP:0002151) | 2.67754751 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.56942640 |
| 36 | Progressive microcephaly (HP:0000253) | 2.51462403 |
| 37 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51378146 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.48662194 |
| 39 | Reduced antithrombin III activity (HP:0001976) | 2.48507794 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 2.47842718 |
| 41 | Large eyes (HP:0001090) | 2.43629386 |
| 42 | Renal Fanconi syndrome (HP:0001994) | 2.43386268 |
| 43 | Microretrognathia (HP:0000308) | 2.39645670 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.39392691 |
| 45 | Lactic acidosis (HP:0003128) | 2.37670744 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.36223894 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34203486 |
| 48 | Loss of speech (HP:0002371) | 2.31849545 |
| 49 | Cerebral palsy (HP:0100021) | 2.31352166 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31246221 |
| 51 | Reticulocytopenia (HP:0001896) | 2.31189882 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.30182854 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30182854 |
| 54 | Thrombocytosis (HP:0001894) | 2.29665325 |
| 55 | Deep palmar crease (HP:0006191) | 2.28146504 |
| 56 | Severe visual impairment (HP:0001141) | 2.28031060 |
| 57 | Split foot (HP:0001839) | 2.27450582 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25486246 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.24643174 |
| 60 | Hypomagnesemia (HP:0002917) | 2.23305646 |
| 61 | Meningitis (HP:0001287) | 2.22248384 |
| 62 | Abnormal hair whorl (HP:0010721) | 2.21715173 |
| 63 | Late onset (HP:0003584) | 2.20858057 |
| 64 | Cellulitis (HP:0100658) | 2.20844366 |
| 65 | Increased CSF lactate (HP:0002490) | 2.16543982 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.16507195 |
| 67 | Eczematoid dermatitis (HP:0000976) | 2.16430810 |
| 68 | Prolonged neonatal jaundice (HP:0006579) | 2.16238043 |
| 69 | Myositis (HP:0100614) | 2.14866971 |
| 70 | Exertional dyspnea (HP:0002875) | 2.13920634 |
| 71 | Petechiae (HP:0000967) | 2.11647919 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10215338 |
| 73 | Respiratory failure (HP:0002878) | 2.09212773 |
| 74 | Type II lissencephaly (HP:0007260) | 2.07902842 |
| 75 | Progressive macrocephaly (HP:0004481) | 2.07814668 |
| 76 | Purpura (HP:0000979) | 2.06295706 |
| 77 | Cortical visual impairment (HP:0100704) | 2.06190591 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06018215 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06018215 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06018215 |
| 81 | Acute encephalopathy (HP:0006846) | 2.05486260 |
| 82 | Increased muscle lipid content (HP:0009058) | 2.05440389 |
| 83 | Hypoventilation (HP:0002791) | 2.04696270 |
| 84 | Increased serum ferritin (HP:0003281) | 2.03997467 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03744324 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.01211258 |
| 87 | Hyperthyroidism (HP:0000836) | 2.00861894 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.00807055 |
| 89 | Hypertensive crisis (HP:0100735) | 2.00602821 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00072506 |
| 91 | Mutism (HP:0002300) | 1.99256813 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 1.98569004 |
| 93 | Death in infancy (HP:0001522) | 1.96419862 |
| 94 | Esotropia (HP:0000565) | 1.96166303 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95803590 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95803590 |
| 97 | Abnormality of pain sensation (HP:0010832) | 1.93767156 |
| 98 | Impaired pain sensation (HP:0007328) | 1.93767156 |
| 99 | Pallor (HP:0000980) | 1.92276299 |
| 100 | Focal motor seizures (HP:0011153) | 1.92275051 |
| 101 | Panhypogammaglobulinemia (HP:0003139) | 1.91351372 |
| 102 | Exercise intolerance (HP:0003546) | 1.90333018 |
| 103 | Gliosis (HP:0002171) | 1.90302107 |
| 104 | Cerebral edema (HP:0002181) | 1.89543681 |
| 105 | Opisthotonus (HP:0002179) | 1.89496183 |
| 106 | Recurrent bacterial skin infections (HP:0005406) | 1.88540122 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 1.88504263 |
| 108 | Increased IgE level (HP:0003212) | 1.86868039 |
| 109 | Ankle clonus (HP:0011448) | 1.86546014 |
| 110 | Restlessness (HP:0000711) | 1.86419290 |
| 111 | Amyloidosis (HP:0011034) | 1.86304491 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86055844 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 1.86055844 |
| 114 | Hyperalaninemia (HP:0003348) | 1.86055844 |
| 115 | Axonal loss (HP:0003447) | 1.85649814 |
| 116 | Stomatitis (HP:0010280) | 1.85589238 |
| 117 | Oligomenorrhea (HP:0000876) | 1.85278103 |
| 118 | Craniofacial dystonia (HP:0012179) | 1.85216655 |
| 119 | Optic disc pallor (HP:0000543) | 1.83368959 |
| 120 | Hypercortisolism (HP:0001578) | 1.83138424 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.82586584 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82586584 |
| 123 | Cholecystitis (HP:0001082) | 1.81437328 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 1.81437328 |
| 125 | Focal dystonia (HP:0004373) | 1.81358154 |
| 126 | Abnormality of reticulocytes (HP:0004312) | 1.80993645 |
| 127 | Abnormal eating behavior (HP:0100738) | 1.80747163 |
| 128 | Torticollis (HP:0000473) | 1.78473037 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.77360118 |
| 130 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76339035 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.76339035 |
| 132 | Abnormal protein glycosylation (HP:0012346) | 1.76339035 |
| 133 | Abnormal glycosylation (HP:0012345) | 1.76339035 |
| 134 | Agitation (HP:0000713) | 1.74756480 |
| 135 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74700566 |
| 136 | Growth hormone excess (HP:0000845) | 1.74279798 |
| 137 | Symptomatic seizures (HP:0011145) | 1.74100080 |
| 138 | Cerebral hypomyelination (HP:0006808) | 1.73278255 |
| 139 | Unsteady gait (HP:0002317) | 1.73048437 |
| 140 | Hypokinesia (HP:0002375) | 1.72817701 |
| 141 | Focal seizures (HP:0007359) | 1.70318806 |
| 142 | Macrocytic anemia (HP:0001972) | 1.69996991 |
| 143 | Neuroendocrine neoplasm (HP:0100634) | 1.69825347 |
| 144 | Abnormality of the motor neurons (HP:0002450) | 1.69677804 |
| 145 | Abnormal neuron morphology (HP:0012757) | 1.69677804 |
| 146 | Retinal dysplasia (HP:0007973) | 1.69178794 |
| 147 | Dysautonomia (HP:0002459) | 1.69176653 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.68424893 |
| 149 | Microvesicular hepatic steatosis (HP:0001414) | 1.68369387 |
| 150 | Broad distal phalanx of finger (HP:0009836) | 1.68081180 |
| 151 | Type I transferrin isoform profile (HP:0003642) | 1.68015153 |
| 152 | CNS demyelination (HP:0007305) | 1.67524312 |
| 153 | Generalized hypopigmentation (HP:0007513) | 1.67108317 |
| 154 | Absence seizures (HP:0002121) | 1.67045085 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.66980556 |
| 156 | Death in childhood (HP:0003819) | 1.66811719 |
| 157 | Increased hepatocellular lipid droplets (HP:0006565) | 1.63370987 |
| 158 | Generalized aminoaciduria (HP:0002909) | 1.58971440 |
| 159 | Vertebral compression fractures (HP:0002953) | 1.58897325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 3.68365919 |
| 2 | MAP3K9 | 3.67658430 |
| 3 | NME2 | 3.47901206 |
| 4 | MAP3K12 | 3.04060813 |
| 5 | KSR2 | 3.03160005 |
| 6 | VRK2 | 2.86691855 |
| 7 | STK16 | 2.58797376 |
| 8 | ERN1 | 2.52339269 |
| 9 | KSR1 | 2.46911362 |
| 10 | CAMKK2 | 2.43954937 |
| 11 | RAF1 | 2.18768147 |
| 12 | SCYL2 | 2.15835292 |
| 13 | NTRK3 | 2.14899589 |
| 14 | BUB1 | 2.06699769 |
| 15 | SIK3 | 2.03362176 |
| 16 | MAP4K2 | 2.03207656 |
| 17 | TESK2 | 1.99395860 |
| 18 | FGFR4 | 1.87569695 |
| 19 | MAP3K13 | 1.73759590 |
| 20 | BRAF | 1.58545220 |
| 21 | MINK1 | 1.54654667 |
| 22 | DYRK2 | 1.54175707 |
| 23 | MARK1 | 1.47599964 |
| 24 | TAOK3 | 1.45229745 |
| 25 | NME1 | 1.43210785 |
| 26 | PIM2 | 1.41839173 |
| 27 | MAP3K11 | 1.38819502 |
| 28 | TAOK1 | 1.38433404 |
| 29 | RIPK4 | 1.37713773 |
| 30 | PAK6 | 1.37318937 |
| 31 | CDK19 | 1.33070344 |
| 32 | DYRK3 | 1.31907416 |
| 33 | CAMKK1 | 1.29963286 |
| 34 | DAPK1 | 1.28534005 |
| 35 | GRK5 | 1.26985240 |
| 36 | IRAK2 | 1.26509256 |
| 37 | LIMK1 | 1.24965352 |
| 38 | EPHA4 | 1.23128208 |
| 39 | IRAK3 | 1.18528571 |
| 40 | TESK1 | 1.16875144 |
| 41 | DAPK2 | 1.16275215 |
| 42 | IKBKB | 1.12303465 |
| 43 | WNK3 | 1.12148418 |
| 44 | TAOK2 | 1.08385025 |
| 45 | DAPK3 | 1.07883378 |
| 46 | ZAP70 | 1.06636033 |
| 47 | MUSK | 1.03057004 |
| 48 | CSNK1G3 | 1.02783277 |
| 49 | MAPKAPK3 | 1.00390429 |
| 50 | AURKA | 0.99625978 |
| 51 | KIT | 0.98596769 |
| 52 | SYK | 0.92632120 |
| 53 | MAP3K2 | 0.91458504 |
| 54 | KDR | 0.91366625 |
| 55 | MAP2K6 | 0.91249644 |
| 56 | MAP2K7 | 0.89834851 |
| 57 | MAP2K3 | 0.89212926 |
| 58 | BCKDK | 0.88467421 |
| 59 | IKBKE | 0.87020193 |
| 60 | TXK | 0.87014316 |
| 61 | CSNK1G2 | 0.85821640 |
| 62 | CSF1R | 0.80992925 |
| 63 | MAP2K1 | 0.79990364 |
| 64 | TBK1 | 0.79305877 |
| 65 | CCNB1 | 0.78588770 |
| 66 | CDK14 | 0.77995076 |
| 67 | MOS | 0.77605159 |
| 68 | PASK | 0.77432027 |
| 69 | CDK18 | 0.75095639 |
| 70 | MAPK13 | 0.74535720 |
| 71 | NTRK1 | 0.74373095 |
| 72 | RPS6KA5 | 0.72696159 |
| 73 | LYN | 0.72290169 |
| 74 | CAMK1 | 0.71682906 |
| 75 | PRKCI | 0.71655131 |
| 76 | RET | 0.71633788 |
| 77 | UHMK1 | 0.71068059 |
| 78 | GRK6 | 0.67633401 |
| 79 | CDK11A | 0.67410671 |
| 80 | CDK15 | 0.66498558 |
| 81 | CDK5 | 0.65686460 |
| 82 | MATK | 0.64450612 |
| 83 | IRAK4 | 0.64321580 |
| 84 | LRRK2 | 0.64038513 |
| 85 | MAP3K1 | 0.62829527 |
| 86 | BRSK1 | 0.62391684 |
| 87 | MAP2K2 | 0.62330814 |
| 88 | RPS6KL1 | 0.60966809 |
| 89 | RPS6KC1 | 0.60966809 |
| 90 | PRKCG | 0.59691665 |
| 91 | TLK1 | 0.59137243 |
| 92 | GRK7 | 0.57785807 |
| 93 | RPS6KA6 | 0.53720129 |
| 94 | FES | 0.53528632 |
| 95 | CSNK1A1L | 0.53167818 |
| 96 | ADRBK2 | 0.52799099 |
| 97 | SRPK1 | 0.52612665 |
| 98 | PRKG2 | 0.52393738 |
| 99 | MAP3K5 | 0.50818928 |
| 100 | MAPK4 | 0.50592634 |
| 101 | CSNK1G1 | 0.49301646 |
| 102 | TYK2 | 0.49194856 |
| 103 | PDPK1 | 0.49113856 |
| 104 | SIK2 | 0.48883916 |
| 105 | DYRK1A | 0.48614188 |
| 106 | MAP2K4 | 0.47989793 |
| 107 | MAPK15 | 0.47744995 |
| 108 | PRKCZ | 0.46946150 |
| 109 | TRIB3 | 0.46714798 |
| 110 | RPS6KA2 | 0.46193374 |
| 111 | BTK | 0.44456383 |
| 112 | FLT3 | 0.43301368 |
| 113 | BMPR2 | 0.42061503 |
| 114 | LCK | 0.41499080 |
| 115 | TNIK | 0.40887551 |
| 116 | MAP4K1 | 0.40496379 |
| 117 | MAP3K14 | 0.40063243 |
| 118 | CAMK2G | 0.39953588 |
| 119 | RPS6KA4 | 0.39860333 |
| 120 | CSK | 0.39556184 |
| 121 | PDK1 | 0.39243256 |
| 122 | DYRK1B | 0.39060425 |
| 123 | NTRK2 | 0.38717081 |
| 124 | VRK1 | 0.38692089 |
| 125 | PRKD3 | 0.38242873 |
| 126 | ABL2 | 0.37799459 |
| 127 | PIM1 | 0.36988788 |
| 128 | MARK3 | 0.36374568 |
| 129 | HCK | 0.36016691 |
| 130 | SGK494 | 0.33815509 |
| 131 | SGK223 | 0.33815509 |
| 132 | BLK | 0.33711650 |
| 133 | TNK2 | 0.33645568 |
| 134 | PRKCD | 0.32942651 |
| 135 | PRPF4B | 0.31332750 |
| 136 | JAK3 | 0.30975414 |
| 137 | INSRR | 0.30606679 |
| 138 | NUAK1 | 0.30587150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39560755 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.37013792 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.18882167 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.99155738 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.77823920 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.49418355 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.43018243 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.41796732 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.41162164 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37640638 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34571375 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.24911232 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 2.22958618 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16885960 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.16068252 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.09584287 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08857330 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03424649 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00449181 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98224257 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.87941738 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.84929713 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84490558 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84389683 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79661151 |
| 26 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.77884746 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.76071381 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70660246 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64770375 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.61350498 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60325186 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59912876 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58718605 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.56857901 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52109499 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.51039336 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41848507 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.36216652 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.34009717 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33919280 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22040802 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21363818 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.20544766 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17570741 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17320225 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13568495 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12765769 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.10252332 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 1.07136816 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04882468 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03287622 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01930634 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01330287 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00183600 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97419587 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97205876 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.96112970 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94137581 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93140795 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93097936 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.91855514 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90881739 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90300327 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89709711 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.86894484 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86433315 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85757472 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85289443 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85267912 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84225744 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83910148 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82156446 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81658439 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.81381813 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80769232 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80387401 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80379636 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79953120 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77803697 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76529746 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74712653 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73102200 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72925529 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72302487 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.72251350 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71941372 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71117294 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70344721 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.70093325 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.69871070 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68163702 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.67534878 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67461211 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66977420 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66959486 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66179894 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64796628 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63880528 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63405586 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.61752360 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61012860 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58806368 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57418219 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57233309 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56926725 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56324136 |
| 107 | Spliceosome_Homo sapiens_hsa03040 | 0.56185966 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54380525 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52915934 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52705086 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52584170 |
| 112 | Mismatch repair_Homo sapiens_hsa03430 | 0.51950524 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50923004 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50692211 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50537728 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50392897 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49458870 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48317015 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47971375 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47913169 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47846435 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46900339 |
| 123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46417308 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.46275583 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.45948480 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44683923 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.44149005 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43548842 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43100159 |
| 130 | Long-term depression_Homo sapiens_hsa04730 | 0.42531708 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41777825 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.41713832 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41264749 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40314781 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.39621274 |
| 136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39406951 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39334618 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.38742636 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.38170234 |
| 140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37584285 |
| 141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37222048 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.34884565 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34172540 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33859881 |
| 145 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33713144 |
| 146 | Salivary secretion_Homo sapiens_hsa04970 | 0.33121990 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32781524 |
| 148 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32062954 |
| 149 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31236853 |
| 150 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29935570 |

